Page 3 - Q3 Results

More Q3 earnings misses than hits by India Inc add pressure to markets

Earnings upgrade-to-downgrade ratio worst in 22 quarters, says Motilal Oswal

ABB India Oct-Dec quarter net profit rises 56% to Rs 528.41 crore

In its press release, the company stated that the full year saw its highest-ever order book of Rs 13,079 crore and revenue of Rs 12,188 crore

Stock Market Close Highlights: Sensex snaps 8-day losing run, gains 702pts from low; Nifty at 22,959

Stock Market Highlights: The BSE Sensex closed at 75,996.86, up 57.65 points or 0.08 per cent from its previous close, and around 702.10 points higher from the intra-day low of 75,294.76

Stock Markets Crash: Nifty levels; strategy after Q3 results, Trump tariffs

Stock Market Crash: Nifty's immediate resistance is placed at 23,810, above which the bearish formation of 'Lower Top-Lower Bottom' gets negated

RVNL share price slips 7% on posting weak Q3; Check out details here

RVNL posted a 13 per cent decline in consolidated net profit to Rs 311.58 crore as compared to a profit of Rs 358.57 crore a year ago

Dilip Buildcon gains 4% despite posting mixed Q3; PAT up 7%, rev down 10%

During Q3 FY25, the company won a tunnel project worth Rs 1,136 crore in the Kozhikode and Wayanad districts of Kerala on an engineering, procurement, and construction (EPC) basis

Utkarsh Small Finance hits all time low on posting Q3 results; Details

Bank's gross non-performing asset (GNPA) stood at Rs 1,176.76 crore as compared to Rs 718.73 crore in Q2

GlaxoSmithKline hits 20% upper circuit on posting 400% jump in Q3 PAT

The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago

Stocks to Watch, Feb 17, 2025: SAIL, Glenmark Pharma, Easy Trip, ABFRL

Stocks to Watch, Feb 17, 2025: Investors will eye stocks of companies that will and have released their Q3 results; ABFRL, Glenmark, SAIL and other will be in focus

Q3 results review: India Inc profits crawl as sales stay sluggish

But operating profit margin of 28.7% the best in 21 quarters

Dr Agarwal's Health Care Q3 results: Net profit grows to Rs 28.24 cr

Dr Agarwal's Health Care Ltd has logged a consolidated profit after tax of Rs 28.24 crore for the October-December 2024 quarter, the company said. The city-headquartered eye care provider had registered a profit after tax of Rs 22.59 crore during the corresponding quarter of last financial year. The company had registered a profit after tax of Rs 67.79 crore for the nine month period ending December 31, 2024 as compared to a profit after tax of Rs 53.73 crore registered in the year ago period. Commenting on the financial performance, Dr Agarwal's Health Care Ltd CEO Dr Adil Agarwal said, "We have delivered a robust growth of 29.5 per cent in revenue and 26.3 per cent in EBITDA. We have continued to witness strong growth in both patient footfalls and the number of surgeries performed." "Our commitment to providing exceptional care, along with investments in cutting-edge technology, positions us for long-term success. While we have maintained our growth trajectory, we remain committe

KK Birla group's sugar companies see drop in net profit in Q3, income up

K K Birla group sugar companies, Magadh Sugar & Energy and Avadh Sugar & Energy, have posted a decline in net profits during the third quarter of current financial year ending December 31, 2024. Net profit of Magadh Sugar dipped to Rs 21 crore in the third quarter as against Rs 39 crore in the same period previous corresponding period. The total income of the company during the third quarter stood higher at Rs 285 crore as compared to Rs 219 crore in the similar corresponding period, a statement by the company said. Similarly, the net profit of Avadh Sugar during the third quarter of the current financial year dipped to Rs seven crore as compared to Rs 22 crore in the previous corresponding period. The total income of the company during the current third quarter stood at Rs 619 crore as against Rs 595 crore in the previous similar period of 2023-24. Co-chairperson of Avadh Sugar C S Nopany the sugar season of 2024-25 has presented a mixed outlook, with challenges such as lower

BSNL Q3 results: Net profit at Rs 262 cr, first quarterly gain in 17 years

BSNL has posted a net profit of Rs 262 crore for December quarter, marking its return to profitability after almost 17 years, Union Minister Jyotiraditya Scindia said on Friday terming it a "significant turning point" for the state-owned telco that has been focused on expansion of service offerings and subscriber base. BSNL scripted an improvement on several counts, clinching 14-18 per cent growth across mobility, FTTH and leased line service offering, Scindia, Minister for Communications said adding that the subscriber base too has risen to about 9 crore in December, from 8.4 crore in June. "Today is an important day for BSNL, and for the journey of the telecom sector in India...BSNL has, in third quarter of FY2024-25, for the first time in 17 years, posted a profit on a quarterly basis. The last time that BSNL posted a quarterly profit was in the year 2007," he said on BSNL's earnings. The net profit came in at about Rs 262 crore in the third quarter of the financial year. Mobilit

Dilip Buildcon's Q3 FY25 results: Profit rises 7.4% to Rs 115.3 crore

The company's revenue from operations declined by 9.98 per cent YoY

Glenmark Pharma Q3 results: Net profit down at Rs 348 cr on weak US sales

The company reported a loss of Rs 351 crore in the comparable quarter last year, hurt by sluggish sales in India and charges related to a legal case settlement in the United States

GlaxoSmithKline Pharma Q3FY25: Net profit rises 400% to Rs 228.58 crore

GlaxoSmithKline Pharmaceuticals on Friday said its net profit increased over five-fold to Rs 229 crore for the third quarter ended December 31, 2024. The drug firm reported a net profit of Rs 45 crore for the October-December quarter of last fiscal. Revenue from operations rose to Rs 949 crore for the third quarter, as compared to Rs 805 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement. "Our strong third-quarter results reflect our unwavering commitment to deliver innovative healthcare solutions to patients across India," GlaxoSmithKline Pharmaceuticals MD Bhushan Akshikar stated. By focusing on core brands and accelerating digital transformation through innovative go-to-market strategies, the company continues to strengthen its market presence while ensuring broader access to medicines and vaccines, he added. The company saw strong performance across key product portfolios during the quarter, the drug firm said. Flagship brands within the genera

Samvardhana Motherson Q3 profit rises to Rs 879 cr, misses estimates

Samvardhana Motherson is India's top auto parts maker by market capitalisation and counts carmakers from Maruti Suzuki to Mercedes-Benz among its customers

Venus Pipes Tubes Q3 results: PAT drops 22% to Rs 18 cr, revenue up 11%

Stainless steel pipes and tubes manufacturers and exporters Venus Pipes & Tubes on Friday reported a 22 per cent fall in net profit to Rs 18 crore for the December quarter of 2024-25 compared to Rs 23.27 crore in the year-ago period. However, the company increased total income by 11.7 per cent in the third quarter to Rs 231.3 crore from Rs 207.1 crore in the same period last year. "Strong export demand continued during the quarter, with exports rising by 153 per cent YoY. Growth was driven by robust demand from the US and Middle East & Africa market for welded pipes and tubes, while European demand continued to remain strong," the company said in a statement. Exports accounted for 38.5 per cent of revenue during the quarter. "Domestically, sales remain impacted by sluggish private and government sector capex," Arun Kothari, Managing Director, Venus Pipes & Tubes Ltd said. For the first nine months of FY25, net profit rose by 14 per cent to Rs 69 crore while revenue was up .

Awfis Q3FY25 results: Net profit at Rs 15.17 cr, income rises to Rs 331 cr

Co-working firm Awfis Space Solutions Ltd has posted a consolidated net profit of Rs 15.17 crore in the third quarter of this fiscal on higher income. The company had posted a net loss of Rs 6.28 crore in the year-ago period. Total income increased to Rs 331.46 crore in the October-December period of this fiscal from Rs 225.77 crore in the corresponding period of the preceding year, according to a regulatory filing on February 11. "Since March 2024, we added around 27,000 seats and 33 centres to reach 1,20,000 seats and 193 operational centers ... We remain confident in reaching our target of 1,35,000 operational seats by March 2025," said Amit Ramani, Chairman and Managing Director, Awfis Space Solutions. Awfis is one of the leading operators of flexible managed office space in the country.

Concord Biotech shares plunge 16% on reporting Q3 results; PAT down 2% YoY

In Q3, Concord Biotech reported a 2 per cent decline in consolidated net profit to Rs 75.9 crore as compared to Rs 77.6 crore a year ago